Free Trial

Insmed (INSM) Earnings Date, Estimates & Call Transcripts

Insmed logo
$68.09
-0.23 (-0.34%)
(As of 11/4/2024 ET)

Insmed Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 27Estimated
Actual EPS
(Oct. 31)
-$1.27 Missed By -$0.08
Consensus EPS
(Oct. 31)
-$1.19

Insmed released Q3 2024 earnings on October 31, 2024, reporting an EPS of -$1.27, which missed the consensus estimate of -$1.19 by $0.08. Quarterly revenue rose 18.1% year-over-year to $93.40 million, above analyst estimates of $93.36 million. With a trailing EPS of -$5.55, Insmed's earnings are expected to grow next year, from ($5.36) to ($4.18) per share.

INSM Upcoming Earnings

Insmed's next earnings date is estimated for Thursday, February 27, 2025, based off prior year's reporting schedules.

Get Insmed Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Insmed and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

INSM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

INSM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Insmed Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$1.19-$1.04-$1.12
Q2 20242-$1.00-$0.98-$0.99
Q3 20242-$1.42-$1.02-$1.22
Q4 20242-$1.42-$1.05-$1.24
FY 20248($5.03)($4.09)($4.56)

Insmed Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/27/2025
(Estimated)
------- 
10/31/2024Q3 2024-$1.19-$1.27 -$0.08-$1.27$93.36M$93.40M      
8/8/2024Q2 2024-$1.22-$1.94 -$0.72-$1.94$87.95M$90.34M        
5/9/2024Q1 2024-$1.22-$1.06+$0.16-$1.06$77.76M$75.50M          
2/22/2024Q4 2023-$1.13-$1.28 -$0.15-$1.28$82.15M$83.70M          
10/26/2023Q3 2023-$1.06-$1.10 -$0.04-$1.09$78.86M$79.07M  
8/3/2023Q2 2023-$1.10-$1.78 -$0.68-$1.78$70.23M$77.23M      
5/4/2023Q1 2023-$1.08-$1.17 -$0.09-$1.17$63.93M$65.20M        
2/23/2023Q4 2022-$1.00-$1.20 -$0.20-$1.19$65.78M$59.30M    

Insmed Earnings - Frequently Asked Questions

Insmed has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 27th, 2025 based off last year's report dates. Learn more on INSM's earnings history.

Insmed updated its FY 2024 earnings guidance on Thursday, October, 31st. The company issued revenue guidance of $340.0 million-$360.0 million, compared to the consensus revenue estimate of $356.6 million.

In the previous quarter, Insmed (NASDAQ:INSM) missed the analysts' consensus estimate of ($1.19) by $0.08 with a reported earnings per share (EPS) of ($1.27). Learn more on analysts' earnings estimate vs. INSM's actual earnings.

The conference call for Insmed's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Insmed's latest earnings report can be read online.
Read Transcript

Insmed's earnings report can be found in their filing with the SEC.
View SEC filing

Insmed (NASDAQ:INSM) has a recorded annual revenue of $305.21 million.

Insmed (NASDAQ:INSM) has a recorded net income of -$749.57 million. INSM has generated -$5.55 earnings per share over the last four quarters.

Insmed's earnings are expected to grow from ($5.36) per share to ($4.18) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:INSM) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners